What is Harvard Apparatus Regenerative Technology Inc.?
, a clinical-stage biotechnology company, focuses on developing regenerative-medicine treatments for disorders of the gastro-intestinal system and other organs resulting from cancer, trauma, or birth defects.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical-stage biotechnology company, focuses on developing regenerative-medicine treatments for disorders of the gastro-intestinal system and other organs resulting from cancer, trauma, or birth defects. Its lead product candidate is Cellspan Esophageal Implant for the treatment of severe esophageal disease. The company is listed on the OTCQB in USA, operating in the Healthcare sector, with a market capitalisation of 30.90M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.